Literature DB >> 17377592

Chronic graft-versus-host disease in the era of reduced-intensity conditioning.

D S Subramaniam1, D H Fowler, S Z Pavletic.   

Abstract

In the past decade the field of hematopoietic stem cell transplantation has entered a new era with the introduction of reduced intensity conditioning (RIC) regimens. The impact of RIC on the incidence of chronic graft-versus-host disease (GVHD) has not been evaluated systematically. Factors confounding such analyses include short follow-up in studies, absence of prospective comparison trials, use of a variety of RIC regimens, lack of uniform GVHD prophylaxis and lack of rigorous criteria for the diagnosis and staging of chronic GVHD. This review discusses factors that appear to influence the incidence and clinical presentation of chronic GVHD in the RIC transplantation era. Overall, RIC seems to decrease the incidence and severity of acute GVHD through day 100 post-transplant when compared to conventional conditioning; however, there is little evidence to suggest that chronic GVHD is reduced after RIC. For the more definitive assessments of chronic GVHD after RIC it will be important to study this question in prospective comparison trials with long duration of follow-up. The recent National Institutes of Health chronic GVHD consensus project recommendations provide now the critically needed standardized guidelines for the diagnosis, classification and staging of chronic GVHD.

Entities:  

Mesh:

Year:  2007        PMID: 17377592     DOI: 10.1038/sj.leu.2404642

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  7 in total

1.  Risk factors and organ involvement of chronic GVHD in Japan.

Authors:  J Kanda; H Nakasone; Y Atsuta; T Toubai; H Yokoyama; T Fukuda; S Taniguchi; K Ohashi; H Ogawa; T Eto; K Miyamura; Y Morishima; T Nagamura-Inoue; H Sakamaki; M Murata
Journal:  Bone Marrow Transplant       Date:  2013-09-30       Impact factor: 5.483

2.  Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.

Authors:  Sally Arai; Mukta Arora; Tao Wang; Stephen R Spellman; Wensheng He; Daniel R Couriel; Alvaro Urbano-Ispizua; Corey S Cutler; Andrea A Bacigalupo; Minoo Battiwalla; Mary E Flowers; Mark B Juckett; Stephanie J Lee; Alison W Loren; Thomas R Klumpp; Susan E Prockup; Olle T H Ringdén; Bipin N Savani; Gérard Socié; Kirk R Schultz; Thomas Spitzer; Takanori Teshima; Christopher N Bredeson; David A Jacobsohn; Robert J Hayashi; William R Drobyski; Haydar A Frangoul; Görgün Akpek; Vincent T Ho; Victor A Lewis; Robert Peter Gale; John Koreth; Nelson J Chao; Mahmoud D Aljurf; Brenda W Cooper; Mary J Laughlin; Jack W Hsu; Peiman Hematti; Leo F Verdonck; Melhelm M Solh; Maxim Norkin; Vijay Reddy; Rodrigo Martino; Shahinaz Gadalla; Jenna D Goldberg; Philip L McCarthy; José A Pérez-Simón; Nandita Khera; Ian D Lewis; Yoshiko Atsuta; Richard F Olsson; Wael Saber; Edmund K Waller; Didier Blaise; Joseph A Pidala; Paul J Martin; Prakash Satwani; Martin Bornhäuser; Yoshihiro Inamoto; Daniel J Weisdorf; Mary M Horowitz; Steven Z Pavletic
Journal:  Biol Blood Marrow Transplant       Date:  2014-10-30       Impact factor: 5.742

3.  A prospective study of an alemtuzumab containing reduced-intensity allogeneic stem cell transplant program in patients with poor-risk and advanced lymphoid malignancies.

Authors:  Craig S Sauter; Joanne F Chou; Esperanza B Papadopoulos; Miguel-Angel Perales; Ann A Jakubowski; James W Young; Michael Scordo; Sergio Giralt; Hugo Castro-Malaspina
Journal:  Leuk Lymphoma       Date:  2014-03-20

Review 4.  Murine models of chronic graft-versus-host disease: insights and unresolved issues.

Authors:  Yu-Waye Chu; Ronald E Gress
Journal:  Biol Blood Marrow Transplant       Date:  2008-02-13       Impact factor: 5.742

Review 5.  Non-myeloablative allogeneic hematopoietic stem cell transplantation.

Authors:  Nonniekaye Shelburne; Margaret Bevans
Journal:  Semin Oncol Nurs       Date:  2009-05       Impact factor: 2.315

6.  Immune Reactions following Cord Blood Transplantations in Adults.

Authors:  Hiroto Narimatsu
Journal:  Stem Cells Int       Date:  2011-06-05       Impact factor: 5.443

Review 7.  Biology of chronic graft-vs-host disease: Immune mechanisms and progress in biomarker discovery.

Authors:  Richard B Presland
Journal:  World J Transplant       Date:  2016-12-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.